Curative Biotechnology (CUBT) Financial Statements

20 Followers

Curative Biotechnology Financial Overview

Curative Biotechnology's market cap is currently $5.11M. The company's EPS TTM is $-0.4054; its P/E ratio is -1.85; Curative Biotechnology is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -87.84K	$ -92.21K	$ -97.52K	$ -7.96K	$ -6.74K
Operating Income	$ -1.50M	$ -2.44M	$ -1.93M	$ -4.47M	$ -5.01M
EBITDA	$ -1.41M	$ -2.35M	$ -2.50M	$ -4.36M	$ -5.16M
Net Income	$ -2.26M	$ -3.56M	$ -3.96M	$ -5.38M	$ -5.34M
Balance Sheet
Cash & Short-Term Investments	$ 45.04K	$ 19.53K	$ 56.40K	$ 58.67K	$ 670.26K
Total Assets	$ 2.11M	$ 2.16M	$ 2.60M	$ 2.09M	$ 2.41M
Total Debt	$ 1.36M	$ 1.37M	$ 2.26M	$ 1.07M	$ 0.00
Net Debt	$ 1.31M	$ 1.35M	$ 2.20M	$ 1.01M	$ -670.26K
Total Liabilities	$ 8.20M	$ 7.08M	$ 5.75M	$ 22.62M	$ 18.77M
Stockholders' Equity	$ -6.09M	$ -4.91M	$ -3.14M	$ -2.54M	$ 1.68M
Cash Flow
Free Cash Flow	$ -868.87K	$ -1.02M	$ -500.63K	$ -1.61M	$ -1.63M
Operating Cash Flow	$ -868.87K	$ -1.02M	$ -486.58K	$ -1.54M	$ -1.60M
Investing Cash Flow	$ 0.00	$ 0.00	$ -14.04K	$ -76.91K	$ -21.33K
Financing Cash Flow	$ 894.38K	$ 985.88K	$ 498.36K	$ 1.00M	$ 2.14M

Currency in USD

Curative Biotechnology Earnings and Revenue History

Income Statement >

Curative Biotechnology Debt to Assets

Balance Sheet >

Curative Biotechnology Cash Flow

Cash Flow >

Curative Biotechnology Forecast EPS vs Actual EPS

Earnings >